Når forløsning er eneste løsning, må bedre screening på plass
Authors:
- Kjell Åsmund Blix SalvesenKSKjell Åsmund Blix Salvesen
- Anne Cathrine StaffASAnne Cathrine Staff
- 22 May 2026
- journal article
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 146 (7)
Abstract
22.05.2026: Invitert kommentar - Innføringen av utvidet screening for preeklampsirisiko har latt vente på seg og er et eksempel på hvordan finansiering og organisering kan hindre forbedringer for gravide og nyfødte.Keywords
This publication has 5 references indexed in Scilit:
- Aspirin delays preeclampsia in women with chronic hypertensionAmerican Journal of Obstetrics and Gynecology, 2025
- Global and regional causes of maternal deaths 2009–20: a WHO systematic analysisThe Lancet Global Health, 2025
- The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practicePregnancy Hypertension, 2022
- Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in NorwayPregnancy Hypertension, 2022
- Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendationsUltrasound in Obstetrics & Gynecology, 2017